182 related articles for article (PubMed ID: 1981190)
1. Dopamine D1 receptor stimulation increases striatal acetylcholine release in the rat.
Damsma G; Tham CS; Robertson GS; Fibiger HC
Eur J Pharmacol; 1990 Sep; 186(2-3):335-8. PubMed ID: 1981190
[TBL] [Abstract][Full Text] [Related]
2. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
Ajima A; Yamaguchi T; Kato T
Brain Res; 1990 Jun; 518(1-2):193-8. PubMed ID: 1975213
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors.
Damsma G; Robertson GS; Tham CS; Fibiger HC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1064-72. PubMed ID: 1837058
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of both dopamine D1 and D2 receptors facilitates in vivo acetylcholine release in the hippocampus.
Imperato A; Obinu MC; Gessa GL
Brain Res; 1993 Aug; 618(2):341-5. PubMed ID: 8104086
[TBL] [Abstract][Full Text] [Related]
5. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
RamÃrez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of release of acetylcholine in the striatum in mice following continuous exposure to selective D1 and D2 dopaminergic agonists.
Wang HY; Zhou LW; Friedman E; Weiss B
Neuropharmacology; 1993 Jan; 32(1):85-91. PubMed ID: 8094235
[TBL] [Abstract][Full Text] [Related]
7. Lesions of the mesotelencephalic dopamine system enhance the effects of selective dopamine D1 and D2 receptor agonists on striatal acetylcholine release.
Robertson GS; Hubert GW; Tham CS; Fibiger HC
Eur J Pharmacol; 1992 Aug; 219(2):323-5. PubMed ID: 1358643
[TBL] [Abstract][Full Text] [Related]
8. D1 and D2 dopamine receptors and the regulation of striatal acetylcholine release in vivo.
Consolo S; Girotti P; Zambelli M; Russi G; Benzi M; Bertorelli R
Prog Brain Res; 1993; 98():201-7. PubMed ID: 7902591
[No Abstract] [Full Text] [Related]
9. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
DeBoer P; Abercrombie ED
J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
[TBL] [Abstract][Full Text] [Related]
10. D1 and D2 dopaminergic regulation of acetylcholine release from striata of freely moving rats.
Bertorelli R; Consolo S
J Neurochem; 1990 Jun; 54(6):2145-8. PubMed ID: 1971013
[TBL] [Abstract][Full Text] [Related]
11. Dopamine depletion preferentially impairs D1- over D2-receptor regulation of striatal in vivo acetylcholine release.
Bertorelli R; Zambelli M; Di Chiara G; Consolo S
J Neurochem; 1992 Jul; 59(1):353-7. PubMed ID: 1351928
[TBL] [Abstract][Full Text] [Related]
12. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.
See RE; Sorg BA; Chapman MA; Kalivas PW
Neuropharmacology; 1991 Dec; 30(12A):1269-74. PubMed ID: 1686300
[TBL] [Abstract][Full Text] [Related]
13. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
Walters DE; Howard SG
Eur J Pharmacol; 1990 Aug; 184(2-3):257-64. PubMed ID: 2150376
[TBL] [Abstract][Full Text] [Related]
14. Effect of continuous exposure to selective D1 and D2 dopaminergic agonists on rotational behavior in supersensitive mice.
Winkler JD; Weiss B
J Pharmacol Exp Ther; 1989 May; 249(2):507-16. PubMed ID: 2566677
[TBL] [Abstract][Full Text] [Related]
15. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
Giorgi O; Biggio G
Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
[TBL] [Abstract][Full Text] [Related]
16. Anticonvulsant action of SCH 23390 in the striatum of the rat.
al-Tajir G; Starr MS
Eur J Pharmacol; 1990 Dec; 191(3):329-36. PubMed ID: 1982269
[TBL] [Abstract][Full Text] [Related]
17. The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. The importance of the post-surgery interval.
De Boer P; Damsma G; Schram Q; Stoof JC; Zaagsma J; Westerink BH
Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):144-52. PubMed ID: 1349159
[TBL] [Abstract][Full Text] [Related]
18. Decreased striatal release of acetylcholine following withdrawal from long-term treatment with haloperidol: modulation by cholinergic, dopamine-D1 and -D2 mechanisms.
Friedman E; Wang HY; Butkerait P
Neuropharmacology; 1990 Jun; 29(6):537-44. PubMed ID: 2200974
[TBL] [Abstract][Full Text] [Related]
19. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
Protais P; Lesourd M; Comoy E
Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
[TBL] [Abstract][Full Text] [Related]
20. New putative selective agonists at the D-1 dopamine receptor: behavioural and neurochemical comparison of CY 208-243 with SK&F 101384 and SK&F 103243.
Murray AM; Waddington JL
Pharmacol Biochem Behav; 1990 Jan; 35(1):105-10. PubMed ID: 1969161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
